pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·1h ago·1 min read
save

Massachusetts Rep. Jake Auchincloss urges Congress to back U.S. biotech instead of targeting China

Oct 15, 2026·read at STAT ↗Positive

At the STAT Summit in Boston, Rep. Jake Auchincloss (D-Mass.) told fellow lawmakers to back the U.S. biotechnology sector without hesitation.

He urged Congress to champion biotech, criticize insurance firms, and turn the United States into a premier hub for biotech research, rather than pursuing protectionist measures aimed at China.

Auchincloss warned that focusing on China’s rise harms America’s own competitiveness, noting that while China is set to become a strong biotech player, the U.S. can still outpace it with stronger domestic support.

His comments echo the biotech industry’s and investors’ call for increased federal funding and faster research pipelines.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Mass. lawmaker Auchincloss favors boosting U.S. biotech over targeting China”

read at STAT ↗
695 words · retrieved 28m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 39m agoThe Trump administration is doubling down on health care fraud investigationsSTAT
  • 2h agoSTAT+: Former FDA commissioners Califf, Gottlieb, Sharpless lay into current HHS leadershipSTAT
  • 3h agoSTAT+: Verastem’s KRAS inhibitor shows promise in pancreatic cancerSTAT
  • 3h agoAfter a melanoma diagnosis, mRNA cancer vaccine delivered a patient hope — and a path forwardSTAT
  • 5h agoSTAT+: Pharmalittle: We’re reading about former FDA head calling DOGE a ‘disaster,’ an AstraZeneca AI deal, and moreSTAT